Suppr超能文献

MVI 严重程度分级对腹腔镜肝切除治疗早期肝细胞癌长期预后的影响:一项多中心研究。

Grading severity of MVI impacts long-term outcomes after laparoscopic liver resection for early-stage hepatocellular carcinoma: A multicenter study.

机构信息

Department of Comprehensive Surgery, Vascular Surgery, Nantong First People's Hospital, Affiliated Hospital 2 of Nantong University, 666 Shengli Road, Chongchuan District, Nantong City, Jiangsu Province, 226014, China.

Department of General Surgery, Nantong Second People's Hospital, 298 Xinhua Road, Gangzha District, Nantong City, Jiangsu Province, 226002, China.

出版信息

Am J Surg. 2024 Dec;238:115988. doi: 10.1016/j.amjsurg.2024.115988. Epub 2024 Sep 24.

Abstract

PURPOSE

To examine the relationship between microvascular invasion (MVI) grading severity and long-term outcomes in early-stage hepatocellular carcinoma (HCC) patients undergoing laparoscopic liver resection (LLR).

METHODS

Patients who had LLR for early-stage HCC were enrolled. According to the grading severity of MVI, patients were classified into M0, M1 and M2. Recurrence-free survival (RFS) and overall survival (OS) among the groups were compared. Univariate and multivariate Cox regression analyses were performed to identify independent risk factors of OS and RFS.

RESULTS

Among 233 patients, MVI grading as M0, M1, and M2 accounts for 122 (52.4 ​%), 84 (36 ​%), and 27 (11.6 ​%) patients, respectively. The median OS and RFS in patients with M0, M1, and M2 were 84.9, 40.1, and 25.2 months; and 76.9, 27.0, and 18.8 months, respectively. Multivariable analyses identified both M1 and M2 to be independent risk factors for OS and RFS.

CONCLUSION

Grading severity of MVI was independently associated with RFS and OS after LLR for early-stage HCC. Patients with MVI, especially those with M2, should receive stringent recurrence surveillance and active adjuvant therapy.

摘要

目的

研究腹腔镜肝切除术(LLR)治疗早期肝细胞癌(HCC)患者中微血管侵犯(MVI)分级严重程度与长期预后的关系。

方法

纳入接受 LLR 治疗的早期 HCC 患者。根据 MVI 分级严重程度,患者分为 M0、M1 和 M2 组。比较各组间无复发生存率(RFS)和总生存率(OS)。采用单因素和多因素 Cox 回归分析确定 OS 和 RFS 的独立危险因素。

结果

233 例患者中,MVI 分级为 M0、M1 和 M2 的患者分别占 122 例(52.4%)、84 例(36%)和 27 例(11.6%)。M0、M1 和 M2 组患者的中位 OS 和 RFS 分别为 84.9、40.1 和 25.2 个月和 76.9、27.0 和 18.8 个月。多因素分析显示 M1 和 M2 均为 OS 和 RFS 的独立危险因素。

结论

MVI 分级严重程度与 LLR 治疗早期 HCC 患者的 RFS 和 OS 独立相关。MVI 患者,尤其是 M2 患者,应进行严格的复发监测和积极的辅助治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验